Capital Analysts, LLC - ARRAY BIOPHARMA INC ownership

Quarter-by-quarter ownership
Capital Analysts, LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$260,000
+796.6%
10,700
+435.0%
0.03%
+650.0%
Q4 2018$29,0002,0000.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 16,618,776$146,079,00012.59%
BVF INC/IL 4,986,186$43,829,0008.81%
First Light Asset Management, LLC 1,000,361$8,793,0003.86%
Crosspoint Capital Strategies, LLC 463,005$4,070,0003.62%
Consonance Capital Management LP 2,723,471$23,912,0002.63%
KOPP INVESTMENT ADVISORS LLC 219,926$1,933,0002.04%
SPHERA FUNDS MANAGEMENT LTD. 900,000$7,911,0002.00%
Orbimed Advisors 16,088,800$141,421,0001.80%
Cormorant Asset Management, LP 1,150,000$10,109,0001.36%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 2,073,680$18,227,0001.26%
View complete list of ARRAY BIOPHARMA INC shareholders